AACR In the News

The American Association for Cancer Research (AACR) has appeared in numerous publications lately, showcasing the breadth of our mission to prevent and cure all cancer. News stories have featured scientific research, interviews with AACR leadership, and a first-person account of cancer’s financial toll.

Read More

A Targeted Therapy Next in Line for Biomarker-based Cancer Drug Approval?

recent data suggest that there is another potential contender for a biomarker-based FDA approval: a targeted therapeutic called larotrectinib (LOXO-101), which showed promising results in adults and children with a variety of cancer types, all of which had one thing in common – fusions involving the gene TRK.

Read More

AACR Welcomes High School Students for National Cancer Research Month

The American Association for Cancer Research (AACR) wrapped up National Cancer Research Month by inviting a group of 50 students from Philadelphia’s George Washington Carver High School for Engineering & Science to the AACR’s Philadelphia headquarters for a morning of conversations about cancer science.

Read More

Catching Childhood Cancers Early: Insights Into the AACR Childhood Cancer Predisposition Workshop

There is perhaps nothing more painful for parents than receiving a cancer diagnosis for their child. Childhood cancers are generally rare, and in the United States, the death rates have …

Read More

Heading Into Summer, Please “Don’t Fry”

Today is National “Don’t Fry Day,” an initiative undertaken by the National Council on Skin Cancer Prevention to encourage sun safety awareness and to remind people to limit their exposure to ultraviolet (UV) radiation, which has been proven to cause skin cancer.

Read More

FDA Approves First Use for an Anticancer Therapeutic Based on Tumor Biomarker, Not Tumor Origin

Tuesday marked a milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced its first approval of an anticancer therapeutic for use based on whether a patient has a tumor with certain biomarkers and not where in the body the tumor originated.

Read More

Scientist↔Survivor Program Participants Spend a Memorable Day on Capitol Hill

US Capitol Building

May is National Cancer Research Month, and for the past 10 years, leaders and members from the American Association for Cancer Research (AACR), the Association of American Cancer Institutes (AACI), and the American Society of Clinical Oncology (ASCO) have converged on Capitol Hill during May to share how cancer research is saving lives and transforming patient care.

Read More